2.33
Schlusskurs vom Vortag:
$2.12
Offen:
$2.08
24-Stunden-Volumen:
399.67K
Relative Volume:
1.02
Marktkapitalisierung:
$141.14M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-64.86M
KGV:
-2.0804
EPS:
-1.12
Netto-Cashflow:
$-55.66M
1W Leistung:
+23.94%
1M Leistung:
+76.52%
6M Leistung:
+111.82%
1J Leistung:
-0.85%
Acumen Pharmaceuticals Inc Stock (ABOS) Company Profile
Firmenname
Acumen Pharmaceuticals Inc
Sektor
Branche
Telefon
617-344-4190
Adresse
1210-1220 WASHINGTON STREET, NEWTON
Vergleichen Sie ABOS mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
ABOS
Acumen Pharmaceuticals Inc
|
2.33 | 128.42M | 0 | -64.86M | -55.66M | -1.12 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
412.22 | 104.45B | 11.39B | 3.64B | 3.50B | 13.99 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
469.36 | 60.95B | 2.46B | -319.09M | -52.09M | -2.4669 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
572.60 | 59.11B | 14.21B | 4.46B | 3.56B | 39.69 |
![]()
ARGX
Argen X Se Adr
|
812.95 | 49.23B | 3.06B | 1.28B | 447.35M | 19.67 |
![]()
ONC
Beone Medicines Ltd Adr
|
320.94 | 35.92B | 4.56B | -176.77M | 225.30M | -1.7177 |
Acumen Pharmaceuticals Inc Stock (ABOS) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2025-06-17 | Eingeleitet | Citigroup | Buy |
2024-07-26 | Eingeleitet | Citigroup | Buy |
2023-12-12 | Eingeleitet | Deutsche Bank | Buy |
2023-07-20 | Fortgesetzt | BofA Securities | Buy |
2023-05-18 | Eingeleitet | Cantor Fitzgerald | Overweight |
2022-07-15 | Eingeleitet | BTIG Research | Buy |
2022-06-30 | Eingeleitet | H.C. Wainwright | Buy |
2022-01-21 | Hochstufung | BofA Securities | Neutral → Buy |
2021-07-26 | Eingeleitet | BofA Securities | Neutral |
2021-07-26 | Eingeleitet | Credit Suisse | Outperform |
2021-07-26 | Eingeleitet | Stifel | Buy |
2021-07-26 | Eingeleitet | UBS | Buy |
Alle ansehen
Acumen Pharmaceuticals Inc Aktie (ABOS) Neueste Nachrichten
Long term hold vs stop loss in Acumen Pharmaceuticals Inc.2025 Earnings Surprises & AI Driven Price Predictions - newser.com
Relative strength of Acumen Pharmaceuticals Inc. in sector analysisJuly 2025 Momentum & Fast Gain Swing Alerts - newser.com
Tools to monitor Acumen Pharmaceuticals Inc. recovery probabilityJuly 2025 Setups & Step-by-Step Trade Execution Guides - newser.com
Acumen Pharmaceuticals Inc. stock retracement – recovery analysisTrade Analysis Summary & Weekly Top Performers Watchlists - newser.com
What to do if you’re stuck in Acumen Pharmaceuticals Inc.2025 Price Momentum & Target Return Focused Stock Picks - newser.com
What the charts say about Acumen Pharmaceuticals Inc. todayQuarterly Portfolio Report & Safe Investment Capital Preservation Plans - newser.com
Is Acumen Pharmaceuticals Inc. stock a top pick in earnings season2025 Winners & Losers & Low Risk Investment Opportunities - newser.com
How Acumen Pharmaceuticals Inc. stock reacts to oil prices2025 Retail Activity & Free Real-Time Market Sentiment Alerts - newser.com
Central Nervous System Biomarkers Market Growth & Industry - openPR.com
What analysts say about Acumen Pharmaceuticals Inc stockMomentum Trading Signals & Stay One Step Ahead of Risk Events - earlytimes.in
Institutional scanner results for Acumen Pharmaceuticals Inc.Quarterly Profit Report & Risk Managed Investment Entry Signals - newser.com
Trend analysis for Acumen Pharmaceuticals Inc. this weekWeekly Profit Recap & AI Driven Price Forecasts - newser.com
Published on: 2025-10-05 05:00:14 - newser.com
Will Acumen Pharmaceuticals Inc. stock return to pre crisis levelsJuly 2025 News Drivers & Safe Swing Trade Setup Alerts - newser.com
Is it time to cut losses on Acumen Pharmaceuticals Inc.July 2025 Trends & Verified Momentum Watchlists - newser.com
Promising Penny Stocks To Watch In September 2025 - Yahoo Finance
Analyzing net buyer seller activity in Acumen Pharmaceuticals Inc.July 2025 Setups & AI Powered Market Entry Ideas - newser.com
Is Acumen Pharmaceuticals Inc a good long term investmentHigh Dividend Yield Stocks & Outstanding Capital Tips - earlytimes.in
Acumen Pharmaceuticals, Inc. $ABOS Shares Sold by Goldman Sachs Group Inc. - Defense World
Finanzdaten der Acumen Pharmaceuticals Inc-Aktie (ABOS)
Umsatz
Nettogewinn
Free Cashflow
ENV
Acumen Pharmaceuticals Inc-Aktie (ABOS) Insiderhandel
Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
---|---|---|---|---|---|---|---|
Zuga Matt | CFO & Chief Business Officer |
Jan 21 '25 |
Sale |
1.60 |
4,364 |
6,986 |
260,646 |
OConnell Daniel Joseph | Chief Executive Officer |
Jan 21 '25 |
Sale |
1.59 |
12,619 |
20,102 |
667,488 |
Meisner Derek M | Chief Legal Officer & Corp Sec |
Jan 21 '25 |
Sale |
1.59 |
3,418 |
5,435 |
161,127 |
Barton Russell | Chief Operating Officer |
Jan 21 '25 |
Sale |
1.61 |
2,914 |
4,692 |
136,117 |
Siemers Eric | Chief Medical Officer |
Jan 21 '25 |
Sale |
1.59 |
3,219 |
5,118 |
170,298 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):